Pharmabiz

Shilpa CDMO launches at CPHI Milan

Shilpa CDMO, a dedicated complex small-molecule contract development and manufacturing organisation will launch next month at ...
Pharmabiz

Evommune reports top-line results from EVO756 phase 2b clinical trials in moderate-to-severe atopic dermatitis

Evommune reports top-line results from EVO756 phase 2b clinical trials in moderate-to-severe atopic dermatitis: Palo Alto, California Thursday, September 10, 2026, 18:00 Hrs [IST] ...
Pharmabiz

NIMHANS, Karnataka government, and Himalaya Wellness Company scale-up Project USHAS to 37 state government hospitals

NIMHANS, Karnataka government, and Himalaya Wellness Company scale-up Project USHAS to 37 state government hospitals: Our Bureau Bengaluru Thursday, September 10, 2026, 17:40 Hrs ...
Pharmabiz

US FDA accepts Nanoscope Therapeutics’ BLA for Mogenry for the treatment of retinitis pigmentosa with severe vision loss

US FDA accepts Nanoscope Therapeutics’ BLA for Mogenry for the treatment of retinitis pigmentosa with severe vision loss: Dallas Thursday, September 10, 2026, 16:00 Hrs [IST] Na ...
Pharmabiz

EpilepsyGTx & Viralgen collaborate to advance AAV gene therapy programme for epilepsy ahead of first-in-human trial

EpilepsyGTx & Viralgen collaborate to advance AAV gene therapy programme for epilepsy ahead of first-in-human trial: London, UK Thursday, September 10, 2026, 17:00 Hrs [IST] Epile ...
Pharmabiz

Neuland Laboratories board approves Rs. 126 crore capex for 134 acres in AP's Kakinada

Neuland Laboratories board approves Rs. 126 crore capex for 134 acres in AP's Kakinada: Our Bureau, Mumbai Thursday, September 10, 2026, 15:50 Hrs [IST] Neuland Laboratories Limit ...
Pharmabiz

Dr Jitendra Singh launches BIO-NIVESH to catalyse investment and scale-up of biotech innovations

Dr Jitendra Singh launches BIO-NIVESH to catalyse investment and scale-up of biotech innovations: Our Bureau, Mumbai Thursday, September 10, 2026, 15:40 Hrs [IST] Union minister o ...
Pharmabiz

NephroPlus launches NephroPlus International Dialysis Academy

NephroPlus launches NephroPlus International Dialysis Academy: Our Bureau, Mumbai Thursday, September 10, 2026, 17:15 Hrs [IST] NephroPlus, Asia’s largest dialysis networks, ann ...
Pharmabiz

MannKind and Rose Pharma ink collaboration agreement to develop an inhaled rapid-acting, short-duration GLP-1 for weight management

MannKind and Rose Pharma ink collaboration agreement to develop an inhaled rapid-acting, short-duration GLP-1 for weight management: Danbury, Connecticut Thursday, September 10, 2 ...
Pharmabiz

MSD inaugurates expanded Hyderabad Tech Centre

MSD (Merck & Co., Inc., Rahway, N.J., USA) announced the opening of its expanded Hyderabad Tech Centre, a new facility supporting enterprise digital technology capabilities across artificial ...
Pharmabiz

AstraZeneca announces tozorakimab demonstrated statistically significant and highly clinically meaningful reduction in COPD exacerbations in OBERON & TITANIA phase III trials

AstraZeneca announces tozorakimab demonstrated statistically significant and highly clinically meaningful reduction in COPD exacerbations in OBERON & TITANIA phase III trials: Cam ...
Pharmabiz

US FDA clears Alebund Pharmaceuticals’ IND application for AP308 for the treatment of IgA nephropathy

US FDA clears Alebund Pharmaceuticals’ IND application for AP308 for the treatment of IgA nephropathy: Shanghai, China Thursday, September 10, 2026, 13:00 Hrs [IST] Alebund Phar ...